Alteron Therapeutics is a biotech startup dedicated to developing innovative drugs for the treatment Alzheimer's disease (AD) and Amyotrophic Lateral Sclerosis (ALS). We target high TDP-43 activity, which is the root cause of neuronal death. By inhibiting TDP-43, out drugs can simultaneously eliminate the three pathological markers of neurodegeneration and their efficacy has been verified in an hTDP-43 transgenic mouse disease model.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 4717 Campus Dr, Kalamazoo,michigan 49008,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- alterontherapeutics.com
- HQ
- Kalamazoo, Michigan
Alteron Therapeutics Questions
Alteron Therapeutics's website is alterontherapeutics.com
Alteron Therapeutics's LinkedIn profile is https://www.linkedin.com/company/alteron-therapeutics
Alteron Therapeutics has
2 employees.
View email and phone details for 2
employees at Alteron Therapeutics.
Alteron Therapeutics's industry is
Pharmaceutical Manufacturing
Alteron Therapeutics's top competitors are
Rose Biosciences,
Hope Pharma,
D2m Biotherapeutics,
Perfinity Biosciences,
Prothera,
Galapagos,
Cyta Therapeutics,
Encor Biotechnology Inc.,
Agulos Biotech Llc,
Zielbio.
Alteron Therapeutics's categories are Pharmaceutical Manufacturing
Alteron Therapeutics's founding year is 2017
